Hay J E
Mayo Clinic, Rochester, Minnesota.
Gastroenterology. 1995 Jan;108(1):276-83. doi: 10.1016/0016-5085(95)90033-0.
Osteopenia in the form of osteoporosis is a common clinical problem associated with chronic cholestatic liver disease, and clinical morbidity from atraumatic fractures is increasing as more patients with PBC and PSC undergo successful liver transplantation. In the absence of symptomatic fractures, the clinical diagnosis may not be evident and must be sought by specific means to assess bone mineral density. The clinical problem has now been defined, but much remains unknown, from etiologic mechanisms to effective therapies. At present, it seems reasonable to provide aggressive supportive therapy in an attempt to maximize skeletal well-being until more effective therapies for osteopenia become available.
以骨质疏松症形式存在的骨质减少是与慢性胆汁淤积性肝病相关的常见临床问题,随着越来越多的原发性胆汁性胆管炎(PBC)和原发性硬化性胆管炎(PSC)患者成功接受肝移植,非创伤性骨折所致的临床发病率正在上升。在没有症状性骨折的情况下,临床诊断可能不明显,必须通过特定方法来评估骨矿物质密度。目前临床问题已得到明确界定,但从病因机制到有效治疗方法仍有许多未知之处。目前,在有更有效的骨质减少治疗方法可用之前,提供积极的支持性治疗以尽量提高骨骼健康状况似乎是合理的。